Menu

Filtros : "Current Pharmaceutical Design" "IFSC" Limpar

Filtros

Limitar por data

  • 1

1 - 3 (3 registros)

  • Artigo de periodico

    Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target (2017)

    Serrão, Vitor Hugo Balasco; Souza, Juliana Roberta Torini de; Romanello, Larissa; Pereira, Humberto d'Muniz

    Fonte: Current Pharmaceutical Design. Unidade: IFSC

    Assuntos: SCHISTOSOMA MANSONI, ESQUISTOSSOMOSE, INIBIDORES DE ENZIMAS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SERRÃO, Vitor Hugo Balasco et al. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Current Pharmaceutical Design, v. 23, n. 45, p. 6967-6983, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612823666171011100532. Acesso em: 16 nov. 2025.

    • APA

      Serrão, V. H. B., Souza, J. R. T. de, Romanello, L., & Pereira, H. d'M. (2017). Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Current Pharmaceutical Design, 23( 45), 6967-6983. doi:10.2174/1381612823666171011100532

    • NLM

      Serrão VHB, Souza JRT de, Romanello L, Pereira H d'M. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target [Internet]. Current Pharmaceutical Design. 2017 ; 23( 45): 6967-6983.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666171011100532

    • Vancouver

      Serrão VHB, Souza JRT de, Romanello L, Pereira H d'M. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target [Internet]. Current Pharmaceutical Design. 2017 ; 23( 45): 6967-6983.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666171011100532

  • Artigo de periodico

    Hybrid materials and nanocomposites as multifunctional biomaterials (2017)

    Follmann, Heveline D. M.; Naves, Alliny Ferreira; Araujo, Rafael A.; Dubovoy, Viktor; Huang, Xiaoxi; Asefa, Tewodros; Silva, Rafael; Oliveira Junior, Osvaldo Novais de

    Fonte: Current Pharmaceutical Design. Unidade: IFSC

    Assuntos: NANOCOMPOSITOS, BIOMATERIAIS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FOLLMANN, Heveline D. M. et al. Hybrid materials and nanocomposites as multifunctional biomaterials. Current Pharmaceutical Design, v. 23, n. 26, p. 3794-3813, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612823666170710160615. Acesso em: 16 nov. 2025.

    • APA

      Follmann, H. D. M., Naves, A. F., Araujo, R. A., Dubovoy, V., Huang, X., Asefa, T., et al. (2017). Hybrid materials and nanocomposites as multifunctional biomaterials. Current Pharmaceutical Design, 23( 26), 3794-3813. doi:10.2174/1381612823666170710160615

    • NLM

      Follmann HDM, Naves AF, Araujo RA, Dubovoy V, Huang X, Asefa T, Silva R, Oliveira Junior ON de. Hybrid materials and nanocomposites as multifunctional biomaterials [Internet]. Current Pharmaceutical Design. 2017 ; 23( 26): 3794-3813.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666170710160615

    • Vancouver

      Follmann HDM, Naves AF, Araujo RA, Dubovoy V, Huang X, Asefa T, Silva R, Oliveira Junior ON de. Hybrid materials and nanocomposites as multifunctional biomaterials [Internet]. Current Pharmaceutical Design. 2017 ; 23( 26): 3794-3813.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666170710160615

  • Artigo de periodico

    Structure-based drug design to overcome drug resistance: challenges and opportunities (2014)

    Ferreira, Rafaela S.; Andricopulo, Adriano Defini

    Fonte: Current Pharmaceutical Design. Unidade: IFSC

    Assuntos: PLANEJAMENTO DE FÁRMACOS, FÁRMACOS (RESISTÊNCIA), FARMACOTERAPIA

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERREIRA, Rafaela S. e ANDRICOPULO, Adriano Defini. Structure-based drug design to overcome drug resistance: challenges and opportunities. Current Pharmaceutical Design, v. 20, n. 5, p. 687-693, 2014Tradução . . Disponível em: https://doi.org/10.2174/138161282005140214161949. Acesso em: 16 nov. 2025.

    • APA

      Ferreira, R. S., & Andricopulo, A. D. (2014). Structure-based drug design to overcome drug resistance: challenges and opportunities. Current Pharmaceutical Design, 20( 5), 687-693. doi:10.2174/138161282005140214161949

    • NLM

      Ferreira RS, Andricopulo AD. Structure-based drug design to overcome drug resistance: challenges and opportunities [Internet]. Current Pharmaceutical Design. 2014 ; 20( 5): 687-693.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/138161282005140214161949

    • Vancouver

      Ferreira RS, Andricopulo AD. Structure-based drug design to overcome drug resistance: challenges and opportunities [Internet]. Current Pharmaceutical Design. 2014 ; 20( 5): 687-693.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/138161282005140214161949
  • 1

1 - 3 (3 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025